About
Beijing Ruibo Pharmaceutical Technology Co., Ltd. / Beijing Ruibo Biotechnology Co., Ltd.
It is a high-tech enterprise certified by the Beijing Municipal Science and Technology Commission. After years of development, it has become a company integrating R&D,
A comprehensive company integrating production and sales.
Beijing Ruibo is mainly responsible for product research and development. It is located in Daxing Pharmaceutical Industry Base, Zhongguancun Science and Technology Park, Daxing District, Beijing. The R&D center is equipped with advanced instruments necessary for chemical product development and quality testing such as liquid chromatography, gas chromatography, and polarimeter. The technical leaders mainly come from world-renowned scientific research institutes such as Columbia University, University of Zurich, Tsinghua University, and Chinese Academy of Sciences, and have rich experience in well-known pharmaceutical companies at home and abroad. Especially in the fields of glycochemistry, nucleoside chemistry, and asymmetric chemistry, it has unique experience and technology. At the same time, it has also accumulated rich experience and technology in enzymatic synthesis. Over the years, it has successively developed sofosbuvir intermediates and fondaparinux. Gankui sodium intermediate, trifluthymidine, telbivudine, decitabine and brobivudine, etc., and has applied for multiple related patents.
Fujian Ruibo Technology Co., Ltd. was established in 2019 and is located in the Economic Development Zone of Mingxi County, Sanming City, Fujian Province. The company covers an area of 40 acres. The newly built workshop is equipped with 51 sets of different types of reactors with a total capacity of nearly 15,000L, which can meet the requirements of 100 kilograms. production needs to hundreds of tons.